A compound of the formula:
1
wherein R
1
is H or a substituent; m is 1-3; Ar is an aromatic group which may be substituted; X is a bond or a divalent straight-chain group having 1-6 atoms which may be substituted; Y is —S—, —O—, or —N(R
2
)— (R
2
is H or a substituent group), Z is —N═ or —C(R
3
)═ (R
3
is H or a hydrocarbon group), ring A is a benzene ring; ring B is a 5- to 7-membered ring which may be substituted, or a salt thereof is useful for eliciting a prostaglandin I
2
receptor agonistic effect.
A compound of the formula
wherein R1 is H or a substituent; m is 1-3; Ar is an aromatic group which may be substituted; X is a bond or a divalent straight-chain group having 1-6 atoms which may be substituted; Y is —S—, —O—, or —N(R2)— (R2 is H or a substituent group), Z is —N═ or —C(R3)═ (R3 is H or a hydrocarbon group), ring A is a benzene ring; ring B is a 5- to 7-membered ring which may be substituted, or a salt thereof is useful for eliciting a prostaglandin I2 receptor agonistic effect.
COMPOUNDS WITH A BENZO[A]CARBAZOLE STRUCTURE AND USE THEREOF
申请人:Università di Pisa
公开号:EP3679044A1
公开(公告)日:2020-07-15
[EN] COMPOUNDS WITH A BENZO[A]CARBAZOLE STRUCTURE AND USE THEREOF<br/>[FR] COMPOSÉS AYANT UNE STRUCTURE BENZO[A]CARBAZOLE ET LEUR UTILISATION
申请人:UNIV PISA
公开号:WO2019049024A1
公开(公告)日:2019-03-14
The invention relates to compounds of general formula (I), and their use for the treatment and diagnosis of degenerative disorders characterised by high cell proliferation and/or tissue degeneration.